Head and Neck Squamous Cell Carcinoma Clinical Trials in Hangzhou, Zhejiang
4 recruitingHangzhou, Zhejiang, China
Showing 1–4 of 4 trials
Recruiting
Phase 2
Pembrolizumab in Combination With Low-dose PFas Neoadjuvant Treatment for Locally Advanced HNSCC
Head and Neck Squamous Cell Carcinoma
Zhejiang Provincial People's Hospital80 enrolled7 locationsNCT05446467
Recruiting
Phase 2
ARTEMIS-006: HS-20093 in Patients With Head and Neck Squamous Cell Carcinoma and Other Solid Tumors
Head and Neck Squamous Cell Carcinoma
Hansoh BioMedical R&D Company170 enrolled25 locationsNCT06007729
Recruiting
Phase 2
A Study of LVGN6051 Combination Therapy in Patient With Head and Neck Squamous Cell Carcinoma (HNSCC)
Head and Neck Squamous Cell Carcinoma
Lyvgen Biopharma Holdings Limited64 enrolled17 locationsNCT06378177
Recruiting
Phase 2
A Prospective Randomized Controlled Study of Immune Checkpoint Maintenance Therapy After Radiotherapy and Chemotherapy for Locally Advanced Head and Neck Tumors Based on Peripheral Blood CD8Tex Detection in Peripheral Blood
Locally Advanced Head and Neck Squamous Cell Carcinoma
Second Affiliated Hospital, School of Medicine, Zhejiang University104 enrolled1 locationNCT06240689